European Archives - Page 106 of 1301 - European Medical Journal

Epigenetic Markers Predict Prostate Cancer Treatment Resistance

Further analysis identified HDAC3 and the glucocorticoid receptor (GR) as key players in drug resistance.

Earlier Bedtime Boosts Next-Day Physical Activity

Going to bed earlier than usual could help increase physical activity the next day, new data from two large-scale sleep studies suggest.

Real-World Validation of Visual Amyloid-PET Scans in Alzheimer’s Diagnostics

Visual amyloid-PET scans show 86% agreement with quantitative reads, confirming reliability in real-world dementia care.

Herpes Viruses Linked to Faster Dementia Biomarker Rises in Women

Herpes virus exposure linked to faster rises in dementia biomarkers for ageing women, shedding light on infection’s role.

Could Melatonin Help Manage Type 2 Diabetes?

Melatonin may improve long-term blood sugar control in Type 2 diabetes, with no significant impact on fasting glucose.

Herbal Emollients Plus Show Promise for Atopic Dermatitis

These findings support the effectiveness of herbal-based emollients plus in managing atopic dermatitis, extending beyond simple hydration to actively aiding in barrier repair and symptom relief.

Ultrasound-Based Tools Offer Breakthrough in Liver Diagnosis

If validated in larger, diverse populations, the VAS-MASH-US score could represent a major advancement in hepatology.

Cryoballoon Ablation and Radiofrequency Equally Effective for Atrial Fibrillation

Cryoballoon ablation matches radiofrequency treatment for persistent atrial fibrillation, CRRF-PeAF trial finds in multicentre study.

Adverse Childhood Experiences in Parents of Children with Sickle Cell Disease

Parents of children with sickle cell disease experience increased adverse childhood experiences and lower resiliency with increased hospital visits.

Europe Faces Uphill Battle Against Extensively Drug-Resistant Tuberculosis

A European cohort study finds only 40% of patients with extensively drug-resistant tuberculosis achieved successful treatment outcomes, with mortality and failure rates remaining high.